Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer between Elderly and Younger Patients: a Study Using the International Pharmacovigilance Database

Overview of attention for article published in Targeted Oncology, October 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 4,519 followers.

RT @PharmacoBx: Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer btw Elderly & Younger Patients #VigiBase https://…

RT @PharmacoBx: Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer btw Elderly & Younger Patients #VigiBase https://…

Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer btw Elderly & Younger Patients #VigiBase https://t.co/eGs1cOozub

Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer betw. Elderly & Younger Patients https://t.co/No9WxvLOkB #VigiBase

RT @TargetOncology: Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer between Elderly and Younger Patients https://…

RT @TargetOncology: Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer between Elderly and Younger Patients https://…

Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer between Elderly and Younger Patients https://t.co/3JTTh8LQRS